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 Abstract    
Objective: To assess the effectivity and safety of misoprostol induced termination of pregnancy in the second 
trimester in women with a history of previous caesarean section.
Materials and Methods: Retrospective analysis of case records from the obstetrics and gynecology department 
of a tertiary care center between January 2009 and February 2012 was performed. Data derived from 219 women, 
who underwent a second trimester termination of pregnancy, was analyzed in terms of demographics, clinical findin-
gs, laboratory and procedural data. The study group consisted of 56 women with a previous caesarean section and 
the control group was composed of 163 women without such a history. Termination of pregnancies was conducted 
by administration of misoprostol at doses of 50-600 mcg intravaginally or by surgical evacuation in cases of failure 
of medical measures.
Results: There was no statistically significant difference between two groups in terms of demographics such as 
age, menarche, number of pregnancies or live births, smoking habit and co-morbidities. Necessity for blood trans-
fusion (p=0.05) and additional procedure for abortion (p=0.056) were found to be similar in both groups. However, 
laparotomy (p=0.004), uterine rupture (p=0.016), hysterotomy (p<0.001) were performed more frequently in the 
study group; while abortion was more likely to occur within 24 hours in the control group (p=0.031). 
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Introduction
There	 is	 a	 constant	 increase	 in	 the	 incidence	 of	 cesarean	
sections	 (CS)	 performed	 leading	 to	 a	 consequent	 increase	 in	
the	 number	 of	women	with	 a	 cesarean	 scar	 [1].	 If	 termination	
of	pregnancies	in	women	who	had	previously	undergone	CS	is	
a	necessity,	 then	 formation	of	a	uterine	 scar	 is	unavoidable	 [2,	
3].	 Since	 uterine	 rupture	 is	 a	 serious	 complication	 and	 major	
concern	in	women	with	CS,	hysterotomy	can	be	needed	for	such	
a	complicated	second-trimester	pregnancies	[1-3].
Regarding	 near-term	 delivery	 and	 early	 medical	 abortion,	
some	 studies	 have	 demonstrated	 a	 low	 risk	 of	 complications	
in	women	with	a	history	of	CS	[2,	4].	Experience	and	data	for	
termination	of	midtrimester	pregnancies	in	women	with	a	uterine	
scar	are	relatively	limited	[1,	5,	6].	Medical	abortion	of	a	second	
trimester	pregnancy	in	women	with	prior	CS	may	call	for	a	more	
careful	management	due	to	increased	likelihood	of	complications	
[6].	It	was	reported	that	the	use	of	misoprostol	might	result	in	an	
increase	in	the	rate	of	uterine	rupture	[7].
Objectives
The	 aim	of	 this	 study	was	 to	 analyze	 the	 risk	of	maternal	
complications	 among	 women	 with	 uterine	 scars	 necessitating	
termination	 of	 second-trimester	 pregnancy	 (TOP)	 using	
misoprostol.	
Materials and methods
A	 total	 of	 219	women	who	 underwent	 a	 second	 trimester	
TOP	(13	 to	24	weeks	of	pregnancy)	 induced	by	administration	
of	 intravaginal	 misoprostol	 at	 the	 obstetrics	 and	 gynecology	
department	 of	 a	 tertiary	 care	 center	 between	 January	 2009	 –
February	 2012	 were	 enrolled	 in	 this	 study.	 The	 study	 group	
included	 all	 women	 with	 a	 history	 of	 at	 least	 one	 previous	
cesarean	 section.	Control	 group	 consisted	of	women	without	 a	
uterine	scar.	Data	were	obtained	from	the	medical	records	after	
the	approval	of	local	Institutional	Review	Board.	Medical	records	
were	reviewed	to	retrieve	demographic,	clinical,	laboratory	and	
procedural	 data.	Two	groups	were	 compared	 in	 terms	 of	 these	
parameters.	
Misoprostol	 (200	mcg	 bid,	Cytotec®,	Ali	Raif	 Pharm.	Co,	
Turkey)	was	administered	at	doses	of	50-600	mcg	with	intervals	
of	 4-6	 hours.	 Total	 daily	 dose	 of	 misoprostol	 ranged	 between	
100-4400	mcg.	The	 route	 of	 administration	was	 vaginal	 in	 all	
patients.	In	cases	of	heavy	bleeding	(>300	mL)	or	when	placenta	
could	not	be	delivered,	women	had	been	kept	under	observation	
for	 some	 time.	 No	 strict	 schedule	 had	 been	 designed	 for	 the	
appropriate	observation	period.	The	retained	placenta	had	been	
removed	 either	 at	 the	 ward	 or	 in	 the	 operating	 theater	 under	
general	 anesthesia.	 Heavy	 bleeding	 had	 been	 accepted	 as	 an	
indication	 for	 urgent	 surgical	 evacuation.	 Clinical	 judgment,	
continuous	 heavy	 bleeding	 and	 ultrasonographic	 findings	
Conclusion: Medical abortion must be carefully used for the termination of second trimester pregnancies in women 
with a history of CS. Increased possibility of uterine rupture and requirement of interventions such as laparotomy or 
hysterotomy is more likely in these patients. 
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 Streszczenie 
Cel: Ocena skuteczności i bezpieczeństwa terminacji ciąży mizoprostolem w drugim trymestrze u kobiet po cięciu 
cesarskim w poprzedniej ciąży.
Materiał i metoda: Wykonano  analizę retrospektywną historii choroby pacjentek oddziału położniczo-gineko-
logicznego ośrodka trzeciego poziomu referencyjnego z okresu od stycznia 2009 do lutego 2012. Uzyskane in-
formacje o 219 kobietach, które przebyły terminację ciąży w drugim trymestrze, poddano analizie pod względem 
danych demograficznych, objawów klinicznych, wyników laboratoryjnych i proceduralnych. Grupa badana składała 
się z 56 pacjentek po cięciu cesarskim w poprzedniej ciąży a grupa kontrolna ze 163 kobiet bez takiej przeszłości. 
Ciążę terminowano przy pomocy mizoprostolu w dawce 50-600mcg podawanego dopochwowo a w przypadku 
niepowodzenia przy pomocy chirurgicznej ewakuacji.
Wyniki: Nie zaobserwowano istotnych statystycznie różnic pomiędzy obiema grupami pod względem czynników 
demograficznych, takich jak: wiek, pierwsza miesiączka, liczba ciąż lub żywych urodzeń, palenie tytoniu i choroby 
współistniejące. Konieczność przetoczenia krwi (p=0,05) i dodatkowe procedury związane z aborcją (p=0,056) były 
podobne w obu grupach. Laparotomia (p=0,004), pęknięcie macicy (p=0,016), histerotomia (p<0,001) występowa-
ły częściej w grupie badanej, natomiast poronienie w ciągu 24 godzin było częstsze w grupie kontrolnej (p=0,031).
Wnioski: Terminacja ciąży za pomocą leków w drugim trymestrze u kobiet po przebytym cięciu cesarskim musi być 
przeprowadzana bardzo ostrożnie. U tych pacjentek istnieje zwiększone ryzyko pęknięcia macicy oraz konieczność 
interwencji, takich jak laparotomia czy histerotomia.
 Słowa kluczowe: drugi trymestr / poronienie / cięcie cesarskie / misoprostol /
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consistent	 with	 uneven	 endometrial	 thickening	 confirmed	
the	 presence	 of	 residual	 tissue.	 Severe	 complications	 such	 as	
hemorrhage	 (defined	as	 an	estimated	 loss	of	≥1000	mL	blood)	
due	to	atony,	placental	retention,	secondary	bleeding	or	uterine	
rupture	and	any	necessity	for	blood	transfusions	were	recorded.	
Generally,	women	without	any	complications	were	discharged	no	
sooner	 than	4	hours	 after	 expulsion	or	D&C.	Laparotomy	was	
performed	to	achieve	hemostasis	surgically	by	ligation	of	vessels	
responsible	 for	 hemorrhage	 and	 total	 abdominal	 hysterectomy	
was	 required	 in	 circumstances	 where	 this	 goal	 could	 not	 be	
accomplished	 via	 laparotomy.	 Hysterotomy	 was	 performed	
transabdominally	when	abortion	did	not	occur	within	72	hours	of	
the	first	misoprostol	insertion	and	the	treatment	was	considered	
to	have	failed	completely.
Statistical	analysis:	Data	were	analyzed	using	the	Statistical	
Package	 for	Social	Sciences	 (SPSS)	software	 (version	13.0	 for	
Windows).	All	differences	associated	with	a	chance	probability	
of	.05	or	less	were	considered	statistically	significant.	Chi	square	
test	was	used	to	evaluate	qualitative	variables,	while	Student	t	test	
was	utilized	to	assess	quantitative	variables.
Results
Pregnancies	of	219	women	had	been	terminated	during	sec-
ond	trimester	(between	13	to	24	gestational	weeks)	using	prosta-
glandins.	From	this	group,	56	women	had	a	history	of	cesarean	
section.	Mean	age	of	the	women	was	29.5±4.95	(14–51)	years.	In	
the	study	group,	median	values	for	maternal	age	(30.1),	and	the	
number	of	gravidities	(4.3),	parities	(2.6)	and	previous	abortions	
(0.9)	were	estimated	as	seen	in	parentheses.	In	the	control	group,	
the	corresponding	median	values	for	maternal	age,	and	the	num-
ber	of	gravidities,	parities	and	previous	abortions	were	29.3,	4.5,	
2.8,	and	0.7	respectively.	
Need	 for	 blood	 transfusion	 and	 an	 additional	 procedure	
for	 induction	 of	 abortion	was	 found	 to	 be	 similar	 in	 the	 study	
and	the	control	groups	(p=0.05	and	p=0.056,	respectively).	The	
rate	for	surgical	evacuation	after	incomplete	or	failed	induction	
of	 abortion	 via	 prostaglandins	was	 statistically	 similar	 in	 both	
groups	 (p=0.176).	 In	 the	 study	group,	 the	 rates	 for	 laparotomy	
(p=0.004),	uterine	rupture	(p=0.016)	and	hysterotomy	(p<0.001)	
were	 significantly	 higher	 than	 the	 control	 group.	 In	 contrast,	
abortion	was	more	likely	to	occur	within	24	hours	in	the	control	
group;	 whereas	 this	 interval	 was	more	 prolonged	 in	 the	 study	
group	(p=0.028).	Mean	dose	of	misoprostol	necessary	to	induce	
abortion	 was	 lower	 in	 the	 study	 group	 (p=0.023).	 In	 patients	
with	CS	history,	 number	 of	CSs	did	 not	 seem	 to	 influence	 the	
likelihood	of	experiencing	laparotomy,	hysterotomy	and	uterine	
rupture.	Rh	incompatibility	was	more	common	in	the	group	with	
a	previous	CS	history	(p=0.03).	Complications	that	occurred	in	
the	study	and	control	groups	are	demonstrated	in	Table	I.	
Discussion
Recently,	the	rate	of	delivery	via	CS	has	increased	worldwide.	
There	is	limited	data	on	TOP	in	women	with	a	previous	history	
of	CS	performed	in	the	second	trimester	[1,4-6].	While	near-term	
spontaneous	 labor	 after	CS	has	 a	0.4%	 risk	of	 uterine	 rupture,	
it	rises	up	to	1.4%	if	labor	is	induced	with	PGs	with	or	without	
oxytocin	[7].	Medical	abortion	using	synthetic	PGs	is	reported	to	
be	effective	and	safe	in	terms	of	complications	and	side	effects	
[4].	
There	 is	 an	 increased	 risk	 of	 uterine	 rupture	 after	 use	 of	
misoprostol	for	induction	of	labor	in	women	with	a	history	of	CS	
[4,8].	Our	data	suggest	that	a	prior	cesarean	section	can	be	a	risk	
factor	for	uterine	rupture	in	women	scheduled	for	termination	of	
a	midtrimester	pregnancy.	In	our	series,	rate	of	uterine	rupture	in	
the	study	and	the	control	groups	were	5.4%	and	0%	respectively.	
Uterine	rupture	may	occur	either	 in	 the	mid-trimester	or	 in	 the	
third	trimester.	Nevertheless,	previous	history	of	cesarean	section	
does	not	contraindicate	use	of	misoprostol	[4].	
However,	 caution	 is	 required	due	 to	higher	 risk	of	 uterine	
rupture	regardless	of	gestational	age	[4].	It	is	noteworthy	that	the	
mean	dose	of	misoprostol	necessary	to	induce	abortion	is	lower	
in	the	cesarean	group.	As	reported	in	other	studies	[4,	8,	9],	we	
observed	no	statistical	difference	between	the	cesarean	and	control	
groups	as	 for	 the	 time	 interval	between	 induction	and	abortion	
and	in	particular	in	the	duration	of	the	abortion	procedure.	Lower	
doses	of	misoprostol	used	in	the	group	of	women	with	previous	
cesarean	section	did	not	affect	the	time	to	abortion	significantly.	
This	 is	 important	 since	 prolonged	 induction	 of	 labor	 (after	 24	
hours)	may	be	correlated	with	a	higher	risk	of	uterine	rupture.	
According	 to	 our	 results,	 laparotomy	 and	 hysterotomy	
were	required	more	frequently	in	the	study	group.	This	may	be	
attributed	 to	adhesions,	synechiae	and	fibrosis	calling	for	 these	
interventions,	which	are	more	likely	to	occur	in	the	presence	of	
uterine	scarring	due	to	previous	CS.
Rate	of	surgical	evacuation	was	similar	 in	 the	groups	with	
and	without	history	of	CS.	Thus,	it	can	be	suggested	that	uterine	
scarring,	adhesions	or	fibrosis	may	not	directly	enhance	the	rate	
of	 surgical	 evacuation.	 Intraoperative	 ultrasonography	 can	 be	
practically	used	for	detection	of	retained	products	of	conception;	
thereby	complication	rates	will	be	reduced	[7].
In	our	study,	the	need	for	blood	transfusion	or	an	additional	
procedure	 for	 induction	 of	 labour	 was	 similar	 in	 both	 groups	
(p=0.05	and	p=0.056,	 respectively).	Chapman	reported	 that	 the	
need	 for	blood	 transfusion	 is	doubled	 in	women	with	prior	CS	
(11.4%	vs.	5.3%)	[6].	
In	our	series,	requirement	of	blood	transfusion	was	similar	
in	both	study	and	control	groups.	Prolonged	medical	 induction	
may	play	an	important	role	for	requirement	of	blood	transfusion.	
Studies on larger series may yield more trustworthy results in 
these	aspects.	
Poor	 response	 to	 medical	 induction	 within	 24	 hours	 was	
more	 common	 in	 the	 patients	with	 a	 history	 of	 CS.	This	may	
be	due	to	scarring	and	adhesions,	which	may	interfere	with	the	
sensitivity	 of	 uterus	 to	 prostaglandins.	 Rh	 incompatibility	was	
more	common	in	patients	with	previous	CS	history.	We	think	this	
finding	may	be	coincidental;	however	 the	only	 explanation	 for	
this	occasion	may	be	the	increased	incidence	of	CS	in	cases	with	
Rh	incompatibility	where	potential	complications	are	expected.
There	is	a	debate	for	the	optimal	agent	to	be	used	for	medical	
TOP	in	the	second	trimester.	In	general,	misoprostol	can	be	used	
for	 the	 induction	 of	 the	 scarred	 uteri	 in	 the	 second	 and	 third	
trimesters.	Further	studies	investigating	misoprostol	as	a	modern	
pharmaceutical	 agent	 for	 TOP	 in	 midtrimester	 gestation	 are	
required	 to	evaluate	 the	appropriate	drug	 regimen	 for	pregnant	
women	with	a	history	of	CS	[7].
In	our	series,	we	have	utilized	misoprostol	in	patients	with	
a	 history	 of	 caesarean	 delivery	 who	 were	 undergoing	 second	
trimester	 abortion.	 Our	 results	 imply	 that	 pregnancy	 can	 be	
©  P o l s k i e  T o w a r z y s t w o  G i n e k o l o g i c z n e Nr 04/2013280
P R A C E  O R Y G I N A L N E
  położnictwo
Abdulkadir Turgut, et al. Misoprostol-induced termination of second-trimester pregnancy in women with a history of cesarean section...
Ginekol Pol. 2013, 84, 277-280 
terminated	 safely	 in	 the	 second	 trimester	 by	 inducing	 vaginal	
delivery	in	these	patients.	
An	important	finding	of	our	study	was	that	a	previous	caesarean	
delivery	does	not	appear	to	increase	the	incidence	of	complications	
(except	for	uterine	rupture)	in	women	whose	pregnancies	will	be	
terminated	in	the	second	trimester	by	induction	of	labour.	Uterine	
rupture	is	the	most	serious	complication	in	cases	with	a	previous	
uterine	scar.	The	risk	of	rupture	has	been	reported	to	be	higher	
when	oxytocin	is	given	concomitantly	with	prostaglandins.	The	
issue	 of	 potentially	 increased	 risk	 of	 complications	 following	
termination	of	pregnancy	with	misoprostol	in	such	cases	remains	
to	be	answered.	Until	then,	we	believe	that	these	patients	should	
be	 carefully	 selected	 and	monitored	 during	 labour.	 In	 order	 to	
estimate	 the	 risk	 of	 uterine	 rupture	 more	 thoroughly,	 studies	
on	 larger	 case	 series	 are	 required,	 probably	 using	 national	 or	
multicentric	cumulative	data.	Our	retrospective	study	possesses	
limitations	in	this	aspect.	Previous	cesarean	section	scar	does	not	
seem	to	increase	perioperative	risk	of	midtrimester	termination	by	
the	laminaria	and	evacuation	technique	[5].
Conclusion
In	conclusion,	medical	abortion	must	be	carefully	used	for	
the	termination	of	second	trimester	pregnancies	in	women	with	
a	 history	 of	 CS.	 Increased	 possibility	 of	 uterine	 rupture	 and	
requirement	of	interventions	such	as	laparotomy	or	hysterotomy	
must	be	kept	in	mind	for	these	patients.	Response	to	prostaglandin	
induced	abortion	must	be	closely	observed.	Insufficient	response	
after	 24	 hours	 may	 alert	 for	 possibility	 of	 complications	 and	
requirement	of	surgical	evacuation.
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Laparatomy 4/56 0/163 0.004*
Uterine rupture 3/56 0/163 0.016*
Hysterectomy - - -
Hysterotomy 8/56 1/163 <0.001*
Mortality - - -
Chorioamnionitis 2/56 5/163 1.000
Surgical evacuation 13/56 30/163 0.29
Additional procedure 26/56 57/163 0.127
*=statistically siginificant
